Clinical trial Recruiting at 2 sites Interventional Ages 18 to 70

Predictors of complications after transosseous Versah maxillary sinus lift

Official title: Predictors For Transosseous Maxillary Sinus Lift Complications: A Prospective Cohort Study

Run by University of Baghdad · NCT07017413 · Data updated 2026-11-12

This project will test whether factors like residual bone height, sinus membrane thickness, and sinus anatomy predict complications after a transosseous (Versah) sinus lift for people needing implants in the back upper jaw.

More Maxillary Sinus trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations2 sites (Baghdad, Bab Almodaum and 1 other locations)
StatusRecruiting
StartedNovember 30, 2024
Main results expectedOctober 30, 2025
Study endsDecember 12, 2025
Registry record updatedJune 12, 2025
Trial IDNCT07017413 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults needing implants in the posterior maxilla with residual bone height under 6 mm, good general health, no chronic sinus disease, and who are non-smokers.

Probably not a fit

Patients with residual bone height greater than 6 mm, a history of chronic sinusitis or prior sinus surgery, active smokers, or those not undergoing a transcrestal approach are unlikely to benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective cohort of partially edentulous patients receiving transcrestal (Versah/Densah) maxillary sinus lifts with or without simultaneous implant placement. Preoperative parameters such as residual bone height, Schneiderian membrane thickness, maxillary sinus ostium patency, bone density, surgical site, and amount of vertical lift are measured by CBCT and clinical exam. Intraoperative and postoperative outcomes including membrane perforation, postoperative sinusitis, implant failure, and need for revision surgery are recorded and related to the measured predictors. The goal is to develop reliable preoperative indicators to improve risk stratification and treatment planning for transosseous sinus augmentation.

Why it matters

Potential benefit: If successful, the results could help clinicians identify patients at higher risk for membrane perforation or sinus complications and tailor surgical planning or select alternative approaches.

How similar studies have gone: Some prior work on osseodensification/Densah burs suggests improved primary stability and lower complication rates, but predictors of complications specifically for purely transcrestal Versah lifts remain incompletely characterized.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1- Patients requiring dental implants in the posterior maxilla with a residual bone height of \< 6 mm.

  2- Good general health and absence of systemic conditions affecting bone healing (e.g., uncontrolled diabetes, osteoporosis).

  3- No history of chronic sinusitis or other significant sinus pathologies

Exclusion Criteria:

* 1- Severe periodontal disease. 2- Residual bone height \> 6 mm. 3- History of previous sinus lift procedures or other maxillofacial surgeries. 4- Smokers.

Where it's running

  • College of Dentistry , University of Baghdad
    Baghdad, Bab Almodaum, Iraq
    Recruiting
  • Planto clinic
    Baghdad, Mansour, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.